2024년에 16억 달러로 추정되는 세계의 D 다이머 검사 시장은 분석 기간인 2024-2030년에 CAGR 4.0%로 성장하며, 2030년에는 20억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 시약·소모품은 CAGR 3.6%를 기록하며, 분석 기간 종료까지 13억 달러에 달할 것으로 예측됩니다. 분석기 부문의 성장률은 분석 기간 중 CAGR 4.8%로 추정됩니다.
미국 시장은 4억 2,590만 달러로 추정, 중국은 CAGR 3.8%로 성장 예측
미국의 D 다이머 검사 시장은 2024년에는 4억 2,590만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 분석 기간인 2024-2030년의 CAGR을 3.8%로 2030년까지 3억 1,790만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 3.7%와 3.4%로 예측됩니다. 유럽에서는 독일이 CAGR 4.3%로 성장할 것으로 예측됩니다.
세계 D-다이머 검사 시장 - 주요 동향 및 촉진요인 정리
D-dimer 검사가 현대 의료 진단에 필수적인 이유는 무엇인가?
D다이머 검사는 심부정맥혈전증(DVT), 폐색전증(PE) 등 혈액 응고 장애를 감지하는 데 사용되는 필수적인 진단 툴입니다. 이 검사는 혈전이 녹을 때 형성되는 단백질 조각인 D다이머의 존재를 측정하여 체내에서 비정상적인 응고 활성을 나타냅니다. 이 검사는 응급의료 및 임상 현장에서 심각한 상태를 신속하고 효과적으로 배제하는 데 중요한 역할을 합니다. 심혈관 질환과 정맥혈전색전증(VTE)의 발병률이 증가함에 따라 D-dimer 검사는 적시에 개입하고 환자의 예후를 개선하기 위해 의료 서비스에서 점점 더 중요한 역할을 하고 있습니다. 효율적이고 정확한 진단 솔루션에 대한 수요가 증가함에 따라 전 세계 병원, 진단센터 및 검사실에서 D-dimer 검사의 사용이 확대되고 있습니다.
기술 혁신은 어떻게 D-다이머 검사를 개선하고 있는가?
기술의 발전은 D-dimer 검사 시장을 변화시키고 있으며, 진단 과정의 정확성, 속도, 편의성을 향상시키고 있습니다. 현장진단(POC) 검사 기기의 혁신으로 응급상황에서 신속한 D다이머 분석이 가능해져 몇 분 안에 결과를 얻을 수 있고, 보다 빠른 임상적 판단을 내릴 수 있게 되었습니다. 자동화된 고감도 측정 시스템도 개발되어 D다이머 측정의 정확도가 향상되고 위양성을 최소화할 수 있게 되었습니다. 여러 바이오마커를 결합하는 멀티플렉스 검사 플랫폼에 D다이머 검사를 통합함으로써, 특히 COVID-19 관련 응고 이상증과 같은 복잡한 병태를 감지하고 관리할 수 있는 진단 능력이 더욱 향상되고 있습니다. 이러한 기술 혁신은 D다이머 검사의 유효성을 높일 뿐만 아니라 다양한 헬스케어 환경에서의 채택을 확대하여 시장 성장에 기여하고 있습니다.
의료 시설에서 D-dimer 검사 도입을 촉진하는 추세는 무엇인가?
조기 진단 및 예방 의료에 대한 관심이 높아지면서 의료 기관에서 D-dimer 검사의 도입이 증가하고 있습니다. 심혈관 질환이 전 세계 주요 사망 원인으로 떠오르면서, 의료 서비스 프로바이더들은 혈전성 질환을 선별하는 빠르고 신뢰할 수 있는 방법으로 D-dimer 검사를 활용하고 있습니다. 또한 POC 진단 솔루션에 대한 수요도 시장 성장을 가속하고 있습니다. 이러한 검사를 통해 의료 전문가가 응급실, 중환자실, 원격지에서 평가를 수행할 수 있기 때문입니다. 또한 COVID-19 팬데믹의 지속적인 영향으로 응고 검사의 중요성이 부각되면서 바이러스 관련 응고 장애를 모니터링하고 관리하기 위한 D-다이머 검사에 대한 수요가 급증하고 있습니다. 이러한 추세는 의료 시스템이 진단 역량 강화에 우선순위를 두고 있으므로 앞으로도 계속될 것으로 예측됩니다.
D-다이머 검사 시장의 성장을 가속하는 요인은 무엇인가?
D-Dimer 검사 시장의 성장은 심혈관 질환 및 혈전성 질환의 유병률 증가, 현장진단(POC) 기술의 발전, 응급의료 현장에서의 신속한 진단에 대한 수요 증가 등 여러 가지 요인에 의해 이루어지고 있습니다. 당뇨병, 비만 등 혈전 위험이 높은 만성질환이 전 세계에서 증가함에 따라 D-dimer 검사에 대한 수요가 더욱 증가하고 있습니다. 자동 분석 및 고감도 분석과 같은 기술 개선으로 검사의 정확성과 효율성이 향상됨에 따라 의료 시설에서 이러한 시스템을 진단 프로토콜에 통합하는 것이 권장되고 있습니다. 또한 COVID-19 팬데믹으로 인해 응고 검사의 중요성이 높아지면서 D-dimer 진단 솔루션에 대한 투자가 촉진되고 있습니다. 이러한 요인들로 인해 D-Dimer 검사 시장은 병원, 검사실, 현장진단(POC) 분야에서 지속적으로 확대되고 있습니다.
부문
제품 유형(시약·소모품, 분석기); 검사 유형(임상 검사실 검사, POC 검사); 용도(심부정맥혈전증(DVT), 폐색전증(PE), 파종성 혈관내 응고 증후군(DIC), 기타 용도); 최종 용도(병원, 진단 센터, 학술·연구기관, 기타 최종 용도)
조사 대상 기업의 예
Abbott Laboratories, Inc.
Alere, Inc.
Beckman Coulter, Inc.
Becton, Dickinson and Company
Bio/Data Corporation
Corgenix
F. Hoffmann-La Roche AG
Helena Biosciences Europe
Siemens Healthcare GmbH
Sysmex Corporation
Thermo Fisher Scientific, Inc.
Trinity Biotech PLC
AI 통합
Global Industry Analysts는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.
Global Industry Analysts는 일반적인 LLM나 업계 고유 SLM에 쿼리 하는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.
관세 영향 계수
Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.
목차
제1장 조사 방법
제2장 개요
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
기타 유럽
아시아태평양
기타 지역
제4장 경쟁
KSA
영문 목차
영문목차
Global D-dimer Testing Market to Reach US$2.0 Billion by 2030
The global market for D-dimer Testing estimated at US$1.6 Billion in the year 2024, is expected to reach US$2.0 Billion by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Reagents & Consumables, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Analyzers segment is estimated at 4.8% CAGR over the analysis period.
The U.S. Market is Estimated at US$425.9 Million While China is Forecast to Grow at 3.8% CAGR
The D-dimer Testing market in the U.S. is estimated at US$425.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$317.9 Million by the year 2030 trailing a CAGR of 3.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 3.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.
Global D-dimer Testing Market - Key Trends & Drivers Summarized
Why Is D-dimer Testing Crucial for Modern Healthcare Diagnostics?
D-dimer testing is an essential diagnostic tool used to detect blood clotting disorders, such as deep vein thrombosis (DVT) and pulmonary embolism (PE). This test measures the presence of D-dimer, a protein fragment that forms when a blood clot dissolves, indicating abnormal clotting activity within the body. It plays a critical role in the emergency and clinical settings, as it helps rule out serious conditions quickly and effectively. Given the rising incidence of cardiovascular diseases and venous thromboembolism (VTE), D-dimer testing has become increasingly vital in healthcare, ensuring timely intervention and improved patient outcomes. As the demand for efficient and accurate diagnostic solutions grows, the use of D-dimer tests is expanding across hospitals, diagnostic centers, and laboratories worldwide.
How Are Technological Innovations Enhancing D-dimer Testing?
Technological advancements are transforming the D-dimer testing market, improving the accuracy, speed, and convenience of diagnostic processes. Innovations in point-of-care (POC) testing devices now allow for rapid D-dimer analysis in emergency settings, providing results in minutes and enabling quicker clinical decisions. Automated and high-sensitivity assay systems have also been developed, enhancing the precision of D-dimer measurements and minimizing false positives. Integration of D-dimer testing into multiplex testing platforms that combine multiple biomarkers is further enhancing diagnostic capabilities, particularly for detecting and managing complex conditions like COVID-19-related coagulopathies. These innovations are not only increasing the effectiveness of D-dimer testing but are also expanding its adoption across various healthcare settings, contributing to market growth.
What Trends Are Driving the Adoption of D-dimer Testing in Healthcare Facilities?
The increased focus on early diagnosis and preventive care is driving the adoption of D-dimer testing in healthcare facilities. With cardiovascular diseases remaining a leading cause of mortality globally, healthcare providers are increasingly utilizing D-dimer tests as a quick and reliable method to screen for thrombotic disorders. The demand for POC diagnostic solutions is also boosting market growth, as these tests enable healthcare professionals to conduct assessments in emergency rooms, intensive care units, and remote locations. Furthermore, the ongoing impact of the COVID-19 pandemic has highlighted the importance of coagulation testing, leading to a surge in demand for D-dimer tests to monitor and manage coagulopathies associated with the virus. This trend is expected to continue as healthcare systems prioritize enhanced diagnostic capabilities.
What Factors Are Driving Growth in the D-dimer Testing Market?
The growth in the D-dimer testing market is driven by several factors, including the rising prevalence of cardiovascular and thrombotic diseases, advancements in POC testing technology, and the expanding need for quick diagnostics in emergency care settings. The global increase in chronic conditions such as diabetes and obesity, which are associated with higher risks of blood clots, is further boosting the demand for D-dimer tests. Technological improvements, such as automated and high-sensitivity assays, are enhancing test accuracy and efficiency, encouraging healthcare facilities to integrate these systems into their diagnostic protocols. Additionally, the impact of the COVID-19 pandemic has elevated the importance of coagulation testing, driving investments in D-dimer diagnostic solutions. The combination of these factors is fueling the expansion of the D-dimer testing market across hospitals, laboratories, and POC settings.
SCOPE OF STUDY:
The report analyzes the D-dimer Testing market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Product (Reagents & Consumables, Analyzers); Test Type (Clinical Laboratory Tests, Point-of-Care Tests); Application (Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC), Other Applications); End-Use (Hospitals, Diagnostic Centers, Academic & Research Institutes, Other End-Uses)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
Select Competitors (Total 11 Featured) -
Abbott Laboratories, Inc.
Alere, Inc.
Beckman Coulter, Inc.
Becton, Dickinson and Company
Bio/Data Corporation
Corgenix
F. Hoffmann-La Roche AG
Helena Biosciences Europe
Siemens Healthcare GmbH
Sysmex Corporation
Thermo Fisher Scientific, Inc.
Trinity Biotech PLC
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Tariff Impact on Global Supply Chain Patterns
Tariff Impact on Global Supply Chain Patterns
D-dimer Testing - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Prevalence of Cardiovascular and Venous Thromboembolism (VTE) Cases
Increasing Use of D-dimer Testing in Point-of-Care Settings
Growth in Demand for High-Sensitivity D-dimer Assays
Technological Advancements in Rapid and Automated D-dimer Testing Devices
Rising Adoption of D-dimer Testing in Emergency and Clinical Settings
Increasing Focus on Preventive Healthcare and Early Diagnosis
Expansion of Telemedicine Services Supporting Remote D-dimer Testing
Integration of D-dimer Testing in Multiplex and Comprehensive Test Panels
Surge in Demand for Home-Based and Self-Monitoring D-dimer Kits
Growth of Diagnostic Laboratories and Testing Facilities Offering D-dimer Services
Rising Use of D-dimer Testing for COVID-19-Related Coagulopathy Assessment
Increasing Collaboration Between Diagnostic Companies and Healthcare Providers
Growth of Healthcare Infrastructure in Emerging Markets Expanding D-dimer Access
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World D-dimer Testing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for D-dimer Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 3: World Historic Review for D-dimer Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 4: World 15-Year Perspective for D-dimer Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 6: World Historic Review for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 7: World 15-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 9: World Historic Review for Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 10: World 15-Year Perspective for Analyzers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Clinical Laboratory Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 12: World Historic Review for Clinical Laboratory Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 13: World 15-Year Perspective for Clinical Laboratory Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Point-of-Care Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 15: World Historic Review for Point-of-Care Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 16: World 15-Year Perspective for Point-of-Care Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Deep Vein Thrombosis (DVT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 18: World Historic Review for Deep Vein Thrombosis (DVT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 19: World 15-Year Perspective for Deep Vein Thrombosis (DVT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Pulmonary Embolism (PE) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 21: World Historic Review for Pulmonary Embolism (PE) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 22: World 15-Year Perspective for Pulmonary Embolism (PE) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Disseminated Intravascular Coagulation (DIC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 24: World Historic Review for Disseminated Intravascular Coagulation (DIC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 25: World 15-Year Perspective for Disseminated Intravascular Coagulation (DIC) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 27: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 28: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 29: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 30: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 31: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 32: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 33: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 34: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 35: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 36: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 37: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 38: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 39: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 40: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
D-dimer Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 41: USA Recent Past, Current & Future Analysis for D-dimer Testing by Product - Reagents & Consumables and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 42: USA Historic Review for D-dimer Testing by Product - Reagents & Consumables and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 43: USA 15-Year Perspective for D-dimer Testing by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Analyzers for the Years 2015, 2025 & 2030
TABLE 44: USA Recent Past, Current & Future Analysis for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 45: USA Historic Review for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 46: USA 15-Year Perspective for D-dimer Testing by Test Type - Percentage Breakdown of Value Sales for Clinical Laboratory Tests and Point-of-Care Tests for the Years 2015, 2025 & 2030
TABLE 47: USA Recent Past, Current & Future Analysis for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 48: USA Historic Review for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 49: USA 15-Year Perspective for D-dimer Testing by Application - Percentage Breakdown of Value Sales for Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications for the Years 2015, 2025 & 2030
TABLE 50: USA Recent Past, Current & Future Analysis for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 51: USA Historic Review for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 52: USA 15-Year Perspective for D-dimer Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
CANADA
TABLE 53: Canada Recent Past, Current & Future Analysis for D-dimer Testing by Product - Reagents & Consumables and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 54: Canada Historic Review for D-dimer Testing by Product - Reagents & Consumables and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 55: Canada 15-Year Perspective for D-dimer Testing by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Analyzers for the Years 2015, 2025 & 2030
TABLE 56: Canada Recent Past, Current & Future Analysis for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 57: Canada Historic Review for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 58: Canada 15-Year Perspective for D-dimer Testing by Test Type - Percentage Breakdown of Value Sales for Clinical Laboratory Tests and Point-of-Care Tests for the Years 2015, 2025 & 2030
TABLE 59: Canada Recent Past, Current & Future Analysis for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 60: Canada Historic Review for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 61: Canada 15-Year Perspective for D-dimer Testing by Application - Percentage Breakdown of Value Sales for Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications for the Years 2015, 2025 & 2030
TABLE 62: Canada Recent Past, Current & Future Analysis for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 63: Canada Historic Review for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 64: Canada 15-Year Perspective for D-dimer Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
JAPAN
D-dimer Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 65: Japan Recent Past, Current & Future Analysis for D-dimer Testing by Product - Reagents & Consumables and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 66: Japan Historic Review for D-dimer Testing by Product - Reagents & Consumables and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 67: Japan 15-Year Perspective for D-dimer Testing by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Analyzers for the Years 2015, 2025 & 2030
TABLE 68: Japan Recent Past, Current & Future Analysis for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 69: Japan Historic Review for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 70: Japan 15-Year Perspective for D-dimer Testing by Test Type - Percentage Breakdown of Value Sales for Clinical Laboratory Tests and Point-of-Care Tests for the Years 2015, 2025 & 2030
TABLE 71: Japan Recent Past, Current & Future Analysis for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 72: Japan Historic Review for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 73: Japan 15-Year Perspective for D-dimer Testing by Application - Percentage Breakdown of Value Sales for Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications for the Years 2015, 2025 & 2030
TABLE 74: Japan Recent Past, Current & Future Analysis for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 75: Japan Historic Review for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 76: Japan 15-Year Perspective for D-dimer Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
CHINA
D-dimer Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 77: China Recent Past, Current & Future Analysis for D-dimer Testing by Product - Reagents & Consumables and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 78: China Historic Review for D-dimer Testing by Product - Reagents & Consumables and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 79: China 15-Year Perspective for D-dimer Testing by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Analyzers for the Years 2015, 2025 & 2030
TABLE 80: China Recent Past, Current & Future Analysis for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 81: China Historic Review for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 82: China 15-Year Perspective for D-dimer Testing by Test Type - Percentage Breakdown of Value Sales for Clinical Laboratory Tests and Point-of-Care Tests for the Years 2015, 2025 & 2030
TABLE 83: China Recent Past, Current & Future Analysis for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 84: China Historic Review for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 85: China 15-Year Perspective for D-dimer Testing by Application - Percentage Breakdown of Value Sales for Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications for the Years 2015, 2025 & 2030
TABLE 86: China Recent Past, Current & Future Analysis for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 87: China Historic Review for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 88: China 15-Year Perspective for D-dimer Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
EUROPE
D-dimer Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 89: Europe Recent Past, Current & Future Analysis for D-dimer Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 90: Europe Historic Review for D-dimer Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 91: Europe 15-Year Perspective for D-dimer Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
TABLE 92: Europe Recent Past, Current & Future Analysis for D-dimer Testing by Product - Reagents & Consumables and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 93: Europe Historic Review for D-dimer Testing by Product - Reagents & Consumables and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 94: Europe 15-Year Perspective for D-dimer Testing by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Analyzers for the Years 2015, 2025 & 2030
TABLE 95: Europe Recent Past, Current & Future Analysis for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 96: Europe Historic Review for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 97: Europe 15-Year Perspective for D-dimer Testing by Test Type - Percentage Breakdown of Value Sales for Clinical Laboratory Tests and Point-of-Care Tests for the Years 2015, 2025 & 2030
TABLE 98: Europe Recent Past, Current & Future Analysis for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 99: Europe Historic Review for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 100: Europe 15-Year Perspective for D-dimer Testing by Application - Percentage Breakdown of Value Sales for Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications for the Years 2015, 2025 & 2030
TABLE 101: Europe Recent Past, Current & Future Analysis for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 102: Europe Historic Review for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 103: Europe 15-Year Perspective for D-dimer Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
FRANCE
D-dimer Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 104: France Recent Past, Current & Future Analysis for D-dimer Testing by Product - Reagents & Consumables and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 105: France Historic Review for D-dimer Testing by Product - Reagents & Consumables and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 106: France 15-Year Perspective for D-dimer Testing by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Analyzers for the Years 2015, 2025 & 2030
TABLE 107: France Recent Past, Current & Future Analysis for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 108: France Historic Review for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 109: France 15-Year Perspective for D-dimer Testing by Test Type - Percentage Breakdown of Value Sales for Clinical Laboratory Tests and Point-of-Care Tests for the Years 2015, 2025 & 2030
TABLE 110: France Recent Past, Current & Future Analysis for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 111: France Historic Review for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 112: France 15-Year Perspective for D-dimer Testing by Application - Percentage Breakdown of Value Sales for Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications for the Years 2015, 2025 & 2030
TABLE 113: France Recent Past, Current & Future Analysis for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 114: France Historic Review for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 115: France 15-Year Perspective for D-dimer Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
GERMANY
D-dimer Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 116: Germany Recent Past, Current & Future Analysis for D-dimer Testing by Product - Reagents & Consumables and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 117: Germany Historic Review for D-dimer Testing by Product - Reagents & Consumables and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 118: Germany 15-Year Perspective for D-dimer Testing by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Analyzers for the Years 2015, 2025 & 2030
TABLE 119: Germany Recent Past, Current & Future Analysis for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 120: Germany Historic Review for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 121: Germany 15-Year Perspective for D-dimer Testing by Test Type - Percentage Breakdown of Value Sales for Clinical Laboratory Tests and Point-of-Care Tests for the Years 2015, 2025 & 2030
TABLE 122: Germany Recent Past, Current & Future Analysis for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 123: Germany Historic Review for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 124: Germany 15-Year Perspective for D-dimer Testing by Application - Percentage Breakdown of Value Sales for Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications for the Years 2015, 2025 & 2030
TABLE 125: Germany Recent Past, Current & Future Analysis for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 126: Germany Historic Review for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 127: Germany 15-Year Perspective for D-dimer Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
ITALY
TABLE 128: Italy Recent Past, Current & Future Analysis for D-dimer Testing by Product - Reagents & Consumables and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 129: Italy Historic Review for D-dimer Testing by Product - Reagents & Consumables and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 130: Italy 15-Year Perspective for D-dimer Testing by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Analyzers for the Years 2015, 2025 & 2030
TABLE 131: Italy Recent Past, Current & Future Analysis for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 132: Italy Historic Review for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 133: Italy 15-Year Perspective for D-dimer Testing by Test Type - Percentage Breakdown of Value Sales for Clinical Laboratory Tests and Point-of-Care Tests for the Years 2015, 2025 & 2030
TABLE 134: Italy Recent Past, Current & Future Analysis for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 135: Italy Historic Review for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 136: Italy 15-Year Perspective for D-dimer Testing by Application - Percentage Breakdown of Value Sales for Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications for the Years 2015, 2025 & 2030
TABLE 137: Italy Recent Past, Current & Future Analysis for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 138: Italy Historic Review for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 139: Italy 15-Year Perspective for D-dimer Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
UNITED KINGDOM
D-dimer Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 140: UK Recent Past, Current & Future Analysis for D-dimer Testing by Product - Reagents & Consumables and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 141: UK Historic Review for D-dimer Testing by Product - Reagents & Consumables and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 142: UK 15-Year Perspective for D-dimer Testing by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Analyzers for the Years 2015, 2025 & 2030
TABLE 143: UK Recent Past, Current & Future Analysis for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 144: UK Historic Review for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 145: UK 15-Year Perspective for D-dimer Testing by Test Type - Percentage Breakdown of Value Sales for Clinical Laboratory Tests and Point-of-Care Tests for the Years 2015, 2025 & 2030
TABLE 146: UK Recent Past, Current & Future Analysis for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 147: UK Historic Review for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 148: UK 15-Year Perspective for D-dimer Testing by Application - Percentage Breakdown of Value Sales for Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications for the Years 2015, 2025 & 2030
TABLE 149: UK Recent Past, Current & Future Analysis for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 150: UK Historic Review for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 151: UK 15-Year Perspective for D-dimer Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
REST OF EUROPE
TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for D-dimer Testing by Product - Reagents & Consumables and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 153: Rest of Europe Historic Review for D-dimer Testing by Product - Reagents & Consumables and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 154: Rest of Europe 15-Year Perspective for D-dimer Testing by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Analyzers for the Years 2015, 2025 & 2030
TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 156: Rest of Europe Historic Review for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 157: Rest of Europe 15-Year Perspective for D-dimer Testing by Test Type - Percentage Breakdown of Value Sales for Clinical Laboratory Tests and Point-of-Care Tests for the Years 2015, 2025 & 2030
TABLE 158: Rest of Europe Recent Past, Current & Future Analysis for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 159: Rest of Europe Historic Review for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 160: Rest of Europe 15-Year Perspective for D-dimer Testing by Application - Percentage Breakdown of Value Sales for Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications for the Years 2015, 2025 & 2030
TABLE 161: Rest of Europe Recent Past, Current & Future Analysis for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 162: Rest of Europe Historic Review for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 163: Rest of Europe 15-Year Perspective for D-dimer Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
ASIA-PACIFIC
D-dimer Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for D-dimer Testing by Product - Reagents & Consumables and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 165: Asia-Pacific Historic Review for D-dimer Testing by Product - Reagents & Consumables and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 166: Asia-Pacific 15-Year Perspective for D-dimer Testing by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Analyzers for the Years 2015, 2025 & 2030
TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 168: Asia-Pacific Historic Review for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 169: Asia-Pacific 15-Year Perspective for D-dimer Testing by Test Type - Percentage Breakdown of Value Sales for Clinical Laboratory Tests and Point-of-Care Tests for the Years 2015, 2025 & 2030
TABLE 170: Asia-Pacific Recent Past, Current & Future Analysis for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 171: Asia-Pacific Historic Review for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 172: Asia-Pacific 15-Year Perspective for D-dimer Testing by Application - Percentage Breakdown of Value Sales for Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications for the Years 2015, 2025 & 2030
TABLE 173: Asia-Pacific Recent Past, Current & Future Analysis for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 174: Asia-Pacific Historic Review for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 175: Asia-Pacific 15-Year Perspective for D-dimer Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
REST OF WORLD
TABLE 176: Rest of World Recent Past, Current & Future Analysis for D-dimer Testing by Product - Reagents & Consumables and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 177: Rest of World Historic Review for D-dimer Testing by Product - Reagents & Consumables and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 178: Rest of World 15-Year Perspective for D-dimer Testing by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Analyzers for the Years 2015, 2025 & 2030
TABLE 179: Rest of World Recent Past, Current & Future Analysis for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 180: Rest of World Historic Review for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 181: Rest of World 15-Year Perspective for D-dimer Testing by Test Type - Percentage Breakdown of Value Sales for Clinical Laboratory Tests and Point-of-Care Tests for the Years 2015, 2025 & 2030
TABLE 182: Rest of World Recent Past, Current & Future Analysis for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 183: Rest of World Historic Review for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 184: Rest of World 15-Year Perspective for D-dimer Testing by Application - Percentage Breakdown of Value Sales for Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications for the Years 2015, 2025 & 2030
TABLE 185: Rest of World Recent Past, Current & Future Analysis for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 186: Rest of World Historic Review for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 187: Rest of World 15-Year Perspective for D-dimer Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
